Breaking Down Barriers: Improving Access to Comprehensive Biomarker Testing for Cancer Patients

Despite the enormous advances in precision cancer treatment over the past 20 years, there are still significant barriers that prevent a majority of cancer patients from being able to access comprehensive biomarker testing — and thus making them unable to take advantage of these targeted, more effective therapies. Biofidelity’s Chief Medical Officer Dr. Wendy Levin shares with the Future of Medicine blog how the company’s “game-changing” technology simplifies  genomic testing to ensure every patient has access to the very best treatment options.

Read on Future of Medicine